This is further supported by our observations of a lack of decrease in RAP protein expression in tauopathies such as frontotemporal lobar degeneration with tau deposition (FTLD‐tau vs. control RAP protein p = .144; see Figure S1). This evidence concerns the gene MAPT and tauopathy.